These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11149979)

  • 1. Treating immune thrombocytopenic purpura and preventing Rh alloimmunization using intravenous rho (D) immune globulin.
    Sandler SG
    Transfus Med Rev; 2001 Jan; 15(1):67-76. PubMed ID: 11149979
    [No Abstract]   [Full Text] [Related]  

  • 2. Consensus conference on anti-D prophylaxis, April 7 & 8, 1997: final consensus statement. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists.
    Urbaniak SJ
    Transfusion; 1998 Jan; 38(1):97-9. PubMed ID: 9482402
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of multiple passively acquired alloantibodies following infusions of IV Rh immune globulin.
    Rushin J; Rumsey DH; Ewing CA; Sandler SG
    Transfusion; 2000 May; 40(5):551-4. PubMed ID: 10827257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of post-transfusion RhD immunization using red cell exchange and intravenous anti-D immunoglobulin.
    Laspina S; O'riordan JM; Lawlor E; Murphy WG
    Vox Sang; 2005 Jul; 89(1):49-51. PubMed ID: 15938740
    [No Abstract]   [Full Text] [Related]  

  • 5. On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.
    Kumpel BM
    Transfusion; 2006 Sep; 46(9):1652-6. PubMed ID: 16965599
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of D sensitization after mismatched transfusion of blood components: toward optimal use of RhIG.
    Ayache S; Herman JH
    Transfusion; 2008 Sep; 48(9):1990-9. PubMed ID: 18564395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous Rh immune globulin for treating immune thrombocytopenic purpura.
    Sandler SG
    Curr Opin Hematol; 2001 Nov; 8(6):417-20. PubMed ID: 11604585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho (D) immune globulin i.v. for prevention of Rh isoimmunization and for treatment of ITP.
    Med Lett Drugs Ther; 1996 Jan; 38(966):6-8. PubMed ID: 8544794
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful prevention of post-transfusion Rh alloimmunization by intravenous Rho (D) immune globulin (WinRho SD).
    Anderson B; Shad AT; Gootenberg JE; Sandler SG
    Am J Hematol; 1999 Mar; 60(3):245-7. PubMed ID: 10072121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policies and procedures related to weak D phenotype testing and Rh immune globulin administration. Results from supplementary questions to the Comprehensive Transfusion Medicine Survey of the College of American Pathologists.
    Domen RE
    Arch Pathol Lab Med; 2000 Aug; 124(8):1118-21. PubMed ID: 10923069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increases in anti-Rh(D) titre following pregnancy.
    Mollison PL
    Vox Sang; 1994; 67(3):326. PubMed ID: 7863638
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravenous anti-D as a treatment for immune thrombocytopenic purpura (ITP) during pregnancy.
    Michel M; Novoa MV; Bussel JB
    Br J Haematol; 2003 Oct; 123(1):142-6. PubMed ID: 14510957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-D exerts a very early response in childhood acute idiopathic thrombocytopenic purpura.
    Moser AM; Shalev H; Kapelushnik J
    Pediatr Hematol Oncol; 2002 Sep; 19(6):407-11. PubMed ID: 12186363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing RhD haemolytic disease of the newborn. Guidelines are not followed in many cases.
    McFadyen IR; Martlew VJ; Howard HL; Clarke CA
    BMJ; 1998 Apr; 316(7138):1165. PubMed ID: 9569417
    [No Abstract]   [Full Text] [Related]  

  • 15. Royal College of Physicians of Edinburgh/Royal College of Obstetricians and Gynaecologists Consensus Conference on anti-D prophylaxis, 7-8 April 1997.
    Br J Haematol; 1997 Jun; 97(4):927-8. PubMed ID: 9217199
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute renal failure after intravenous anti-D immune globulin in an adult with immune thrombocytopenic purpura.
    Chun NS; Savani B; Seder RH; Taplin ME
    Am J Hematol; 2003 Dec; 74(4):276-9. PubMed ID: 14635210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with anti-D in the treatment of idiopathic thrombocytopenic purpura.
    Scaradavou A; Bussel JB
    Semin Hematol; 1998 Jan; 35(1 Suppl 1):52-7. PubMed ID: 9523749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kleihauer testing. Need not be abandoned.
    Love EM; Shwe KH
    BMJ; 1994 Sep; 309(6957):805. PubMed ID: 7950581
    [No Abstract]   [Full Text] [Related]  

  • 19. Preventing Rh immunisation.
    Letsky EA; de Silva M
    BMJ; 1994 Jul; 309(6949):213-4. PubMed ID: 7848416
    [No Abstract]   [Full Text] [Related]  

  • 20. Mitigation strategies for anti-D alloimmunization by platelet transfusion in haematopoietic stem cell transplant patients: a survey of NCCN
    Poston JN; Sugalski J; Gernsheimer TB; Marc Stewart F; Pagano MB
    Vox Sang; 2020 May; 115(4):334-338. PubMed ID: 32080868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.